Pfizer Limited (BOM:500680)

India flag India · Delayed Price · Currency is INR
5,435.75
+28.60 (0.53%)
At close: Jul 15, 2025
12.03%
Market Cap 248.46B
Revenue (ttm) 22.81B
Net Income (ttm) 7.68B
Shares Out n/a
EPS (ttm) 167.79
PE Ratio 32.37
Forward PE 36.41
Dividend 165.00 (3.00%)
Ex-Dividend Date Jul 9, 2025
Volume 1,023
Average Volume 2,979
Open 5,412.55
Previous Close 5,407.15
Day's Range 5,407.55 - 5,499.00
52-Week Range 3,742.90 - 6,452.85
Beta n/a
RSI 41.81
Earnings Date Aug 14, 2025

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a netwo... [Read more]

Industry Pharmaceutical Preparations
Founded 1950
Employees 1,598
Stock Exchange Bombay Stock Exchange
Ticker Symbol 500680
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was 22.81 billion, an increase of 4.02% compared to the previous year's 21.93 billion. Earnings were 7.68 billion, an increase of 39.23%.

Financial Statements

News

There is no news available yet.